NEORANKER
Dead / Abandoned — Abandoned — failure to respond (as of 23 Jan 2025)
What this means for you
This application is over — abandoned 06 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98292345
- Mark type
- Stylized text
- Filed
- 30 Nov 2023
- Abandoned
- 06 Jan 2025
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Medical and veterinary preparations for therapeutic purposes; preparations for cancer therapy; antibodies; vaccines; preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
- Class 009 — Scientific and electric apparatus: Bioinformatics software; computer software platforms
- Class 040 — Treatment of materials: Custom manufacture of therapeutic drugs; namely custom manufacture of cell therapies and cancer therapies
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Software as a service; providing a bioinformatics platform for manufacturing therapeutics; providing a bioinformatics platform for identifying neoantigens
- Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies
Owner
- Achilles Therapeutics UK Limited, London, GB
Prosecution history
- 23 Jan 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 23 Jan 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 30 Sept 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Sept 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jul 2024 — NON-FINAL ACTION E-MAILED
- 05 Jul 2024 — NON-FINAL ACTION WRITTEN
- 28 Jun 2024 — ASSIGNED TO EXAMINER
- 23 Feb 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Nov 2023 — NEW APPLICATION ENTERED